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Liver fibrosis is an abnormal wound healing response and a common consequence
of chronic liver diseases from infection or alcohol/xenobiotic exposure. At the cellular
level, liver fibrosis is mediated by trans-differentiation of hepatic stellate cells (HSCs),
which is driven by persistent hepatic and systemic inflammation. However, impaired
enterohepatic circulation and gut dysbiosis may indirectly contribute to the liver
fibrogenesis. The composition of the gut microbiota depends on diet composition and
host factors. In this study, we examined chlorophyllin, derived from green pigment
chlorophyll, on gut microbiota, the intestinal mucosal barrier, and liver fibrosis. BALB/c
mice received carbon tetrachloride through intraperitoneal injection to induce liver
fibrosis and chlorophyllin was administrated in drinking water. The effects of chlorophyllin
on liver fibrosis were evaluated for (1) survival rate, (2) hepatic morphologic analysis,
(3) inflammatory factors in both the small intestine and liver, and (4) gut microbiota.
Our results indicate that oral administration of chlorophyllin could attenuate intestinal
and hepatic inflammation and ameliorate liver fibrosis. Importantly, oral administration of
chlorophyllin promptly rebalanced the gut microbiota, exhibiting down-regulation of the
phylum Firmicutes and up-regulation of the phylum Bacteroidetes. In vitro experiments
on intestinal epithelial cells showed that chlorophyllin exposure could inhibit NF-κB
pathway via IKK-phosphorylation suppression. In conclusion, this study demonstrates
potential application of chlorophyllin to regulate the intestinal microbiota and ameliorate
hepatic fibrosis.
Keywords: sodium copper chlorophyllin, liver fibrosis, intestinal tissue barrier, gut microbiota dysbiosis, NF-κB
pathway
Abbreviations: CCl4, carbon tetrachloride; CHL, Chlorophyllin; HSCs, hepatic stellate cells; LPS, lipopolysaccharides; TNF-
alpha, tumor necrosis factor-alpha.
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INTRODUCTION
Cirrhosis is a common consequence of various types of
chronic liver diseases, derived from viral infection, alcohol
abuse and drug/xenobiotic exposure, bile duct obstruction, and
fatty liver (steatosis). At the cellular basis, liver fibrosis us
the trans-differentiation or activation of hepatic stellate cells
(HSCs) (Rippe and Brenner, 2004; Friedman, 2008). As vitamin
A storing cells located in the space of Disse in the liver,
quiescent HSCs are the major hepatic parenchymal cells that
produce the extracellular matrix (ECM) to support the normal
liver cellular architecture in the form of hepatic sinusoids.
Chronic hepatic necro-inflammation, derived from liver injury
and infection, is a major driving force for liver fibrosis. For
instance, our previous work showed that interleukin-1 as an
injury signal was able to activate HSC through expressing
matrix metalloproteinases (MMPs), which consequently could
release transforming growth factor-beta (TGF-beta) stored in
the ECM scaffolds in the space of Disse (Lu et al., 2013).
Persistent inflammation and repeating cycles of infection/injury
and wound healing can lead to excessive wound healing and
scarring, which results in cirrhosis, while genetic depletion
of the interleukin-1 receptor or neutralization of Tregs can
attenuate liver fibrogenesis (Gieling et al., 2009; Zhang et al.,
2016).
On the other hand, gut microbiota is critical for host health
and well-being. Gut microbes assume many physiological
functions for their hosts such as the production of vitamin
B series, energy harvesting from undigested diet, and the
promotion of host immunity and antagonizing foreign invasion.
In contrast, dysbiosis, mediated via the production of endotoxin,
bacterial antigenic debris (including DNA fragments), and
metabolites, is detrimental for the host. It has been reported
that gut bacterial translocation, measured via bacterial DNA
and peptide fragments as well as enterohepatic circulation, can
elicit inflammation and promote liver fibrosis (Neugebauer et al.,
2008; Cano et al., 2010; Bellot et al., 2013). The enterotype
of the gut microbiota is determined by host immunity
and environmental factors including dietary composition.
Consuming green vegetables, due to the green pigment
(chlorophyll) in addition to dietary fibers and vitamins, has
been suggested to impact human health and physiological
functions. Chlorophyllin, derived from chlorophyll, is a
major component that has been widely used as a green
pigment in the food industry. A clinical trial suggested that
chlorophyllin administration could reduce the effects of
aflatoxin and improved liver carcinogenesis (Egner et al.,
2001). In chemically induced animal models of carcinogenesis,
dietary supplementation of chlorophyllin was found to protect
the animal from genomic instability (Vidya Priyadarsini
et al., 2012). Similarly, carcinogen induced rat forestomach
carcinogenesis could be ameliorated by dietary chlorophyllin
via modulation of TGF-beta signaling and downstream target
genes associated with cell proliferation, apoptosis evasion,
angiogenesis, invasion, and metastasis (Thiyagarajan et al.,
2014). Whether dietary supplementation with chlorophyllin can
modulate gut microbiota and impact liver injury and cirrhosis
remains completely unknown. In this study, we measured such
effects and found that chlorophyllin can promptly modulate the
gut microbiota and reduce hepatic inflammation to relieve liver
fibrosis.
MATERIALS AND METHODS
Liver Fibrosis Model and Chlorophyllin
Treatment
All animal experimental procedures in this study complied with
guidelines as outlined in the “Guide for the Care and Use of
Laboratory Animals” (National Research Council, United States).
The animal protocols were approved by the Institutional Animal
Care and Use Committee, the College of Life Sciences, Sichuan
University. Briefly, 4–5 week old BALB/c male mice (Beijing
HFK Bioscience) were maintained in a controlled environment
(12:12 light-dark cycle) with free access to both food and
water. After 2 weeks of adaptation, the mice were randomly
divided into three groups: control, fibrosis, fibrosis treated
with chlorophyllin (n = 5–7 per group); and the experiment
was repeated. The liver fibrosis of mice was induced via
intraperitoneal injections of carbon tetrachloride (CCl4, twice
per week in a progressive regimen: 0.5 µL/g body weight
for the first two treatments, then 1.5 µL/g for the next two
treatments, and 2.0 µL/g for additional 6 weeks) for total
8 weeks. One group of mice was treated with same volume
of mineral oil as control. One group of fibrotic mice was
treated by chlorophyllin (Chengdu Tongdei Pharmaceuticals,
China) in the drinking water at a dose of 25 µg/mL.
Actual volume of consumption was recorded. Averagely, mice
drink 3–5 mL per day. Pure drinking water was applied
for the control and fibrosis groups. According to our daily
observation, the green pigment did not cause any sign of
abnormality or sickness. At the end of experiment, the mice
were sacrifice through cervical dislocation. The liver, ileum
tissues, and fecal pellets were collected and stored at −80◦C for
analysis.
Short-Term Oral Administration of
Chlorophyllin on Intestinal Microflora of
the Mice With Liver Fibrosis
BALB/c male mice under liver fibrotic induction by CCl4
treatment for 4 weeks were randomly divided into two groups
and received (1) low dose (5 µg/g body weight), or (2) high
dose chlorophyllin (25 µg/g). Fresh fecal pellets were collected
at 0, 2, 4, and 8 h. for microflora analysis (n = 2–4 for each
condition).
Plasma Lipopolysaccharide (LPS) and
Cytokine Measurements
he plasma LPS concentration was determined via Limulus
Amebocyte Extract kit (Chinese Horseshoe Crab Reagent
Manufactory, Xiamen, China). Plasma was diluted in the
processing buffer into 1/10, and heated for 10 min at 70◦C.
Then the plasma LPS content was analyzed following the
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manufacturer’s instruction. Plasma TNF-α concentration was
analyzed using ELISA kit (Mercodia, Uppsala, Sweden).
Histological Analysis
Liver tissues were fixed in 4% paraformaldehyde, and
Hematoxylin, and Eosin (H&E) staining was used for
histologic analysis. Liver fibrosis was determined through
Masson’s Trichrome staining. and the sizes of fibrotic septa
were quantitated via densitometry. Lymphocyte infiltration in
the liver was determined via anti-CD3 (Abcam, Cat. 16669,
United States). Colorimetric images for H&E and Masson’s
Trichrome staining were captured via Nikon eclipse Ti-U
microscope. Tight junctions in the ileum were examined using
immunofluorescent staining with anti-occludin (Santa Cruz
Biotechnology, Cat. SC5562, United States) and all images were
captured via the Leica TCS SP5 II system.
Western Blot Analysis
The ileum tissues were homogenized and lysed in RadioImmuno
Precipitation Assay (RIPA) buffer containing protease
inhibitors. The concentration of total protein was detected
by Pierce bicinchoninic acid assay (BCA) Protein Assay Kit
(Thermo, United States). Equal quality of protein samples
was resolved via sodium dodecyl sulfate polyacrylamide gel
electrophoresis and transferred to polyvinylidene difluoride
(PVDF) membranes. The membranes were blocked in 5% nonfat
milk and hybridized to primary antibodies against I-kappa-
B, phosphor-I-kappa-B, IKK, phosphor-IKK (Cell Signaling
Technology), or GAPDH (Zen BioScience, Cat. EE0618, China),
followed by incubation with horse radish peroxidase (HRP)-
conjugated secondary antibodies. Images were developed via
Immobilon Western Chemiluminescent substrate (Millipore,
United States).
RT-qPCR Analysis
The liver or ileum tissue was homogenized in 1 mL Trizol and
total RNA was extracted. The RNA was converted to cDNA
via the Transcriptor First Strand cDNA Synthesis Kit (Roche,
Cat. 04897030001, United States). The qPCR system contained
2 µL cDNA, 0.2 µL forward primer, and 0.2 µL reverse primer
(200 nM), 5 µL MIX, and DEPC water was added to 10 µL.
The reaction was performed with a Bio-Rad machine Cfx96.
The primer sequence information is listed in Table 1. The
relative mRNA expression was normalized to the expression
of RPL-19.
Gut Microbiota Analysis
SYBR green-based qPCR analysis of 16S rRNA genes was used to
quantitate the relative abundance of gut bacteria. Fecal microbe
DNA was extracted using stool DNA kit (Omega, China). The
qPCR system contained 2 µL DNA, 0.2 µL forward primer,
0.2 µL reverse primer (200 nM), 5 µL MIX, and DEPC water
was added to 10 µL. Then, it was analyzed with the Bio-Rad
Cfx96 and the value was expressed as the percentage of common
bacterial readouts as internal reference (Table 2). The accuracy
of the qPCR based 16 rDNA analysis was previously validated by
sequencing the PCR products.
TABLE 1 | The list of RT-qPCR primers for mice.
Gene Forward primer, 5′ > 3′ Reverse primer, 5′ > 3′
TNF-α TGGGACAGTGACCTGGACTGT TTCGGAAAGCCCATTTGAGT
IL-1β TCGCTCAGGGTCACAAGAAA CATCAGAGGCAAGGAGGA
AAAC
IL-6 CTTCCATCCAGTTGCCTTCTTG AATTAAGCCTCCGACTTGT
GAAG
Coll-1 GCTCCTCTTAGGGGCCACT CCACGTCTCACCATTGGGG
Coll-3 GCACAGCAGTCCAACGTAGA GCTTCTTTTCCTTGGGGTTC
TGF-β CTTCAGCTCCACAGAGAAGA GACAGAAGTTGGCATGGTAG
α-SMA TCCAGCCATCTTTCATTGGGA CCCCTGACAGGACGTTGTTA
ZO-1 ACCCGAAACTGATGCTGTGGATAG AAATGGCCGGGCAGAACTT
GTGTA
Occludin ATGTCCGGCCGATGCTCTC TTTGGCTGCTCTTGGGTCT
GTAT
MMP-2 CAACGGTCGGGAATACAGCAG CCAGGAAAGTGAAGGGGA
AGA
MMP-9 AAACCTCCAACCTCACGGAC CTGAAGCATCAGCAAAGCCG
MMP-13 GACCCCAACCCTAAGCATCC CCTCGGAGACTGGTAATGGC
MMP-14 ATCTCACAGCTCGGTGTGTGTTCA AAGGTCAGAGGGTCTTGCCT
TCAA
TIMP-1 GCATGGACATTTATTCTCCACTGT TCTCTAGGAGCCCGATCTG
TIMP-2 GCCAAAGCAGTGAGCGAGAAG GGGGAGGAGATGTAGCA
AGGG
TABLE 2 | The list of microbiota 16S rDNA primer.
Gene Forward primer (5′ > 3′) Reverse primer (5′ > 3′)
All bacteria ACTCCTACGGGAGGCAGCAG ATTACCGCGGCTG
CTGG
Firmicutes GGAGTATGTGGTTTAATTCGAAGCA AGCTGACGACAACC
ATGCAC
Bacteroidetes GGAGCATGTGGTTTAATTCGATGAT AGCTGACGACAACCA
TGCAGG
Impact of Chlorophyllin on the
Inflammatory Signaling Pathways of
Intestinal Epithelial Cells
The intestinal epithelial cells HT-29 and HCT-116, from colon
cancer, were pretreated with chlorophyllin at 50 µM for 60 min
prior to being challenged with endotoxin (LPS) at 0.5 µg/mL
for 15 min. Nuclear and cytoplasmic protein fractionations
were separated according to the manufacturer’s instructions
(Beyotime Nuclear and Cytoplasmic Protein Extraction Kit,
China). Briefly, about 5.0 × 105 cells for each condition were
prepared in cytoplasmic lysis buffer and the nuclear protein
was isolated via nuclear extraction buffer. Protein concentration
was measured using the Pierce BCA Protein Assay kit. The
preparation of cytoplasmic and nuclear fractions followed
previously described methods (Yang et al., 2017). Cytoplasmic
fractions were monitored via Western blot analysis for GAPDH
and beta-actin and nuclear fractions were confirmed via histone
H3 and nuclear lamin A/C. In such frames, nuclear translocation
of Nuclear factor κB (NF κB)-p65 and NFκ B-p50 were
measured.
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Statistical Analysis
The data was analyzed with the software of GraphPad Prism5 and
the Statistical significance was determined via T-tests. The results
are presented as Means ± SEM. Significance was assumed for a
∗p< 0.05 or a ∗∗p< 0.01.
RESULTS
Liver Fibrosis Induced by CCl4 in Mice
Was Ameliorated by Oral Administration
of Chlorophyllin
BALB/c male mice were randomly divided into three groups: (1)
control, (2) liver fibrosis, (3) fibrosis treated with chlorophyllin,
as described in the section of Materials and Methods. Liver
fibrosis of mice was induced via repeating intraperitoneal
injection of carbon tetrachloride (CCl4) for 8 weeks. Another
group of the mice under fibrotic treatment was additionally
treated by chlorophyllin in the drinking water at a dose of
25 µg/mL (equivalent of 5 mg/kg body mass), Figure 1A.
As shown in Figure 1B, the body mass of mice under CCl4
treatment decreased significantly after 7–8 regimens of toxin
treatment. Chlorophyllin treatment moderately restored the body
mass, but without statistical significance. About 50% of the mice
under CCl4 treatment died over the course of the experiment,
while chlorophyllin treatment reduced the mortality to 25%
(Figure 1C). Histological examination via H&E staining showed
large-scale of inflammation, accumulation of leukocytes, and
necrosis in the parenchyma of the liver in response to CCl4
treatment (Figure 1D). Chlorophyllin treatment significantly
reduced such necro-inflammation and liver injury in addition to
improved mortality. Fibrosis developed with CCl4 treatment over
8 weeks, as shown with Masson’s Trichrome staining, showing
fibrotic septa and partial nodulation (Figures 1E,F). In contrast,
chlorophyllin treatment significantly reduced morphological
liver fibrosis. We further determined the extent of fibrogenesis
with a blind fibrotic scoring system and imaging analysis on the
Sirius Red staining. As shown in Figures 1G,H, chlorophyllin
treatment substantially reduced the liver fibrosis scores.
Chlorophyllin Treatment Increased the
MMP/TIMP Ratio, Which May Promote
Fibrolysis and Resolving Liver Fibrosis
There are two types of MMPs. One group (including MMP2
and MMP14) is constitutively expressed in most tissue and
responsible for the turnover of ECM and tissue homeostasis,
while the second group (including MMP9 and MMP13)
is involved in tissue injury and fibrogenesis. Conversely,
MMP activities are inhibited by Tissue Inhibitors of Matrix
Metalloproteinases (TIMPs). As far, the net activity of ECM
turnover or fibrosis regression depends on the ratio of MMPs
over TIMPs. Our previous work demonstrated the critical roles
of MMPs in liver injury, repair, and resolution, relying on the
subtypes of the proteinases and tissue inhibitors (Han et al.,
2004; Qin and Han, 2010; Lu et al., 2013). Indeed, the results
of the Western blot analysis showed that the protein levels of
alpha-smooth muscle actin and fibronectin were elevated in
the liver tissue of mice under fibrotic treatment. However, the
oral administration of chlorophyllin could fully down regulate
these major fibrotic proteins. Liver fibrosis was also quantitated
via RT-qPCR analysis (Figure 2A). As shown in Figure 2A,
the transcription levels of alpha-smooth muscle actin, type-I
collagen, type-III collagen, and transforming growth factor beta-
1 were significantly up-regulated in response to CCl4 treatment
for 8 weeks, which is in line with the morphological evidence
of liver fibrogenesis. In contrast, chlorophyllin treatment
ameliorated these transcriptional parameters of liver fibrosis,
also in agreement with the readouts of morphological fibrosis.
The hepatic protein levels of alpha-smooth actin and fibronectin
were increased in the course of liver fibrosis (Figure 2B).
And oral administration of the green pigment, chlorophyllin,
could partially suppress the expression of these fibrotic proteins
in the liver. The protein levels of MMP9 and MMP13 were
increased in the fibrotic liver, indicating dynamic turnover of
fibrotic ECM in the course of fibrogenesis (Figure 2C). However,
chlorophyllin did not impact on these two MMPs. Importantly,
TIMP1, the tissue inhibitor for MMP9/MMP13 (injury type
MMPs) was significantly down regulated by chlorophyllin
treatment, while TIMP2, the tissue inhibitor for MMP2/MMP14
(constitutive MMPs) was not impacted by administration of
chlorophyllin. The ratio of MMP9/TIMP1 and MMP13/TIMP1
showed increments in the liver after chlorophyllin treatment,
indicating that administration of chlorophyllin may promote the
fibrolysis and resolving liver fibrosis (Figure 2D). Taken together,
these results from multi-parameter analysis indicate that oral
administration of chlorophyllin attenuated liver fibrosis, likely via
elevation of the MMP/TIMP ratio, which consequently promotes
the resolution of liver fibrosis, as demonstrated in the animal
model.
Liver Inflammation Is Attenuated by Oral
Administration of Chlorophyllin
Hepatic fibrosis, as a protective measure and wound-healing
program, is driven by local and systemic inflammation, featured
by cytokines and growth factors. As shown in Figures 3A,B,
infiltration of CD3+ lymphocytes was evident and accumulated
around the central vein of the fibrotic liver. Oral administration
of chlorophyllin reduced the infiltration of the T cells in
the parenchyma of the liver inflammatory lesion. Accordingly,
expression of inflammatory cytokines including interlukin-1beta,
interleukin-6, and tumor necrosis factor-alpha was increased
in the fibrotic liver, but it was suppressed by chlorophyllin
(Figure 3C). Systemic inflammation as determined by serum
TNF-alpha levels was also elevated in fibrotic mice but it was
down regulated by chlorophyllin treatment (Figure 3D). Plasma
endotoxin levels were measured by serum LPS, which indicated
that gut bacterial translocation was suppressed by chlorophyllin
treatment (Figure 3E). Bacterial translocation in combination
with microbial toxin and immunogenic components, through
activation of pattern recognition receptors (PRR), are known to
facilitate liver fibrosis (Neugebauer et al., 2008; Zhang et al., 2016;
Shi et al., 2017).
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FIGURE 1 | CCl4 induced liver fibrosis in mice is ameliorated by oral administration of chlorophyllin. BALB/c male mice were randomly divided into three groups:
control, fibrosis, fibrosis treated with chlorophyllin (n = 6 and repeating twice). Liver fibrosis of the mice was induced via intraperitoneal injection of carbon
tetrachloride (CCl4) for 8 weeks. Oral administration of chlorophyllin was conducted by adding to drinking water at a dose of 25 µg/mL (equivalent 5 mg/kg body
mass). (A) Sketch of the experimental design. (B) Changing body mass. (C) Survival rate. (D) Hematoxylin and Eosin staining of the liver tissues. (E) Masson’s
Trichrome staining for liver fibrosis. (F) Sirius Red staining for liver fibrosis. (G) Fibrosis scores have been determined with pathologists in a blind manner.
(H) Semi-quantitative determination of fibrosis stained by Sirius Red. ∗P < 0.05, ∗∗P < 0.01. ∗/∗∗ Comparisons have been indicated with bars. Data show
Means ± SEM.
We showed recently that the hepatic macrophages undergo
drastic transition from M1 phenotypes to M2 phenotypes along
with liver fibrosis (Bai et al., 2017). Here, we confirmed the
notion and found that oral administration of chlorophyllin
could effectively down regulate the expression of IL-13, a major
cytokine and marker to M2 macrophages (Figure 3F). Thus, these
results imply that chlorophyllin exerted efforts to improve liver
fibrosis is likely mediated by a reduction of systemic and hepatic
inflammation, the driving force for tissue fibrosis.
Impairment of the Small Intestine in Liver
Fibrotic Mice Is Improved by Oral
Administration of Chlorophyllin
Increased bacterial translocation as indicated by endotoxemia
and systemic TNF-alpha indicated either impairment or
damage of the small intestine over the course of liver
fibrogenesis. Histological examination via H&E staining showed
the impairment of small intestine at the distal region, namely the
ileum, of mice with liver fibrogenesis (Figure 4A). The length
of microvilli was noticeably shortened and the muscular externa
was thinner in the ileum of liver fibrotic mice (Figure 4B).
The Goblet cell numbers in the villi were decreased in
the ileum from liver fibrotic mice (Figure 4C). In contrast,
oral administration of chlorophyllin ameliorated this damage
of the small intestine. Moreover, the mRNA levels of tight
junction proteins such as ZO1 and occludin were down
regulated in the ileum of the liver fibrotic mice (Figure 4D).
Oral administration of chlorophyllin partially restored the
expression of tight junction proteins (Figures 4E,F). Chronic
intestinal inflammation could damage tight junctions of the
enterocytes which leads to bacterial translocation (Schulzke
et al., 2009). As expected, the mRNA levels of interleukin-
1beta and TNF-alpha were increased in the ileum of the
liver fibrotic mice, indicating elevation of inflammation, but
were reduced through oral administration of chlorophyllin.
Western blot analysis also showed down-regulation of the
proteins of ZO1 and occludin in the distal region of the small
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FIGURE 2 | Chlorophyllin treatment increases MMP/TIMP ratio, which may promote fibrosis resolution. (A) Reverse transcription coupled quantitated PCR analysis
(RT-qPCR) analysis was used to quantitate liver fibrosis, shown the mRNA levels of alpha-smooth actin, type-I collagen, type-III collagen, and transforming growth
factor beta-1. (B) Western blot analysis of liver fibrosis by where alpha-smooth muscle actin and fibronectin were examined. (C) Western blot analysis of matrix
metalloproteinases (MMP9 and MMP13) and corresponding tissue inhibitors of matrix metalloproteinases (TIMP1, TIMP2). (D) Ratio of MMP9/TIMP1 and
MMP13/TIMP1 based on densitometry data. ∗P < 0.05, ∗∗P < 0.01. ∗/∗∗ Comparisons have been indicated with bars. Data show Means ± SEM.
intestine in mice undergoing fibrogenesis. Importantly, oral
administration of chlorophyllin restored these tight junction
proteins in the ileal tissues. Taken together, these results
demonstrate that oral administration of chlorophyllin could
attenuate local inflammation and restores tight junctions and
integrity of the small intestine, which offers a sufficient
explanation for the observed reduction of endotoxemia in liver
fibrosis.
Exposure of Intestinal Epithelial Cells
With Chlorophyllin Can Attenuate
Inflammatory Signaling Pathways
We speculated that the chlorophyllin treatment might directly
impact on the intestinal epithelial cells to attenuate intestinal
inflammation in the CCL4 induced fibrotic mice. Inflammatory
cytokines such as TNF-alpha and interleukin-1 share common
pathways including IKK and JNK cascades. Here, we examined
the distal regions of the small intestine from the mices
for IKK expression and activation. The results showed that
the phosphorylation of IKK was significantly increased in
the ileum of fibrotic mice, and the oral administration of
chlorophyllin could partially suppress the IKK activation
in the ileal tissue (Figure 5A). Intestinal epithelial cells
(HCT-116) were pretreated with chlorophyllin at 50 µM for
60 min prior to the challenge with endotoxin (LPS) or TNF-
alpha for 15 min (Figure 5B). As shown, challenging the
intestinal cells with LPS or TNF-alpha could activate IKK, as
indicated via increased phosphorylation of the kinases. The
downstream target, I-kappa B, was phosphorylated, followed
by the proteasome-mediated degradation. Treatment with
chlorophyllin attenuated the IKK/I-kappa B pathway, indicating
that the targeting is likely upstream of the pathway. Since
LPS and TNF-alpha bind to different receptors, chlorophyllin
can unequivocally block their activation, indicating a common
target in the membrane complex. We then obtained the
cellular fractionation to measure the nuclear localization for
NF-kappa B/p65. Using HT-29 cells, nuclear protein was
marked via histone H3 and the nuclear matrix (lamin A/C),
while cytoplasmic proteins were indicated via GAPDH. As
shown in Figure 5C, a portion of p65 NF-kappa B, in
addition to its p50 partner, were translocated into the nuclear
compartment in response to LPS stimulation. Chlorophyllin
treatment partially suppressed the activation of the NF-kappa
B pathway. We then tested the anti-inflammatory effect of
chlorophyllin on hepatocyte. As shown in Supplementary
Figure 1, chlorophyllin treatment suppressed the LPS-induced
upregulation of inflammatory cytokine (interleukin-1 beta and
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FIGURE 3 | CCl4 induced liver inflammation is attenuated by oral administration of chlorophyllin. (A,B) CD3+ lymphocytes were measured via immunohistochemical
staining. The CD3+ cells are indicated by green arrows. (C) Expression of inflammatory cytokines including IL-1beta, IL-6, and TNF-alpha detected via RT-qPCR
analysis. (D) Systemic inflammation as the plasma TNF-alpha levels was determined via ELISA analysis. (E) Plasma endotoxin levels are measured by Limulus
Amebocyte Extract kit. (F) Expression of interleukin-13 was detected by RT-qPCR analysis. ∗P < 0.05, ∗∗P < 0.01. ∗/∗∗ Comparisons have been indicated with
bars. Data show Means ± SEM.
interleukin-6) expression on dose-dependent pattern in HepG2
cell line.
Dysbiosis Occurring in Liver Fibrosis Can
Be Rebalanced by Oral Administration of
Chlorophyllin for Eubiosis
Dysbiosis contributes greatly to bacterial translocation and
endotoxemia in liver fibrosis (Gomez-Hurtado et al., 2011;
De Minicis et al., 2014; Giannelli et al., 2014). As shown in
Figures 6A–E, for the control mice, the phylum of Bacteroidetes,
which consists of Gram-negative bacteria, were dominant in
the fecal microbes. About 59% of gut bacteria beyond to
Bacteroidetes, while 14% were Firmicutes. In contrast, in the
fibrotic mice, the population was drastically altered, showing
loss of Bacteroidetes (29% of the total) and gain of Firmicutes
(40% of the total). Such dysbiosis, showing down regulation
of Bacteroidetes and gain of Firmicutes, resembles in many
ways to our work on NASH animal models, where liver
fibrosis was evidently associated with a loss of Bacteroidetes
and increased endotoxemia by the mice under high fat
diet feeding (Su et al., 2016). Importantly, administration of
chlorophyllin restored Bacteroidetes, which sufficiently explains
the reduction of endotoxin in the plasma and consequently
reduced both hepatic inflammation and fibrogenesis. A linear
regression analysis for the association of dysbiosis and liver
fibrosis scores showed a clear positive association between the
scores of liver fibrosis and dysbiosis (elevation of Firmicutes).
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FIGURE 4 | Impairment of small intestine by the liver fibrotic mice is improved by oral administration of chlorophyllin. (A) Histological examination via H&E staining of
the distal region of small intestine. (B) The length of villi in the ileum was determined via Photoshop analysis based on H&E staining. (C) The Goblet cell numbers in
the villi of the distal region of the small intestine were determined by counting in 5 views under microscopy. (D) The tight junction proteins including ZO1 and
occludin, and pro inflammatory cytokines such as IL-1beta and TNF-alpha in the ileum were measured via RT-qPCR analysis. (E) Proteins of ZO1 and occludin in the
distal region of the small intestine were detected via Western blot analysis. (F) The relative amount of tight junction proteins was semi-quantitated via densitometry
analysis. ∗P < 0.05, ∗∗P < 0.01. ∗/∗∗ Comparisons have been indicated with bars. Data show Means ± SEM.
The changing gut microbiota through long-term treatment
may derive from direct impact of chlorophyllin on the
microbes or via the host innate immunity such as secretion
of anti-microbial peptides. For such regard, we tested if
chlorophyllin could directly impact on the gut microbiota in
an acute manner. The liver fibrotic mice were given two
doses of chlorophyllin by oral administration, and the gut
microbiota was measured. As shown in Figures 6F–H, after oral
administration for 2–4 h, the Firmicutes in fecal samples were
significantly reduced, while the abundance of Bacteroidetes was
restored, indicating that chlorophyllin might directly impact gut
microbiota.
DISCUSSION
In this study, we show that the green-plant pigment in
the form of chlorophyllin can ameliorate liver fibrosis. We
furthermore explored the underlying potential mechanism. Liver
fibrosis, or cirrhosis, is abnormal wound healing. Instead of
restoration of the tissue structures with properly organized
epithelia and stroma texture, fibrosis generates fibroplasia,
featured by an accumulation of stiff fibrotic ECM and contractile
myofibroblasts. Independent of the actual causes, either microbial
infection or toxin exposure (alcohol abuse and xenobiotics),
activation or trans-differentiation of hepatic fibrosis is the basis
of the fibrogenesis. Wound healing is driven by growth factors
such as TGF-beta, which are stored as latent forms in the
ECM. MMPs produced by stellate cells are responsible for
the release of growth factors as previously demonstrated by
animal models (Lu et al., 2013). Induction and maturation
of MMPs relies on inflammatory signals such as IL-1 and
TNF-alpha from leukocytes through inflammatory pathways
(Han et al., 2001, 2004). It has been reported that bacterial
translocation and endotoxemia from gut are critical for systemic
and hepatic inflammation (Zhang et al., 2010). This has
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FIGURE 5 | Exposure of intestinal epithelial cells with chlorophyllin can attenuate inflammatory signaling pathways. (A) Western blot analysis for IKK and its
phosphorylation by the distal region of small intestine of the mice as described in Figure 1. (B) In vitro experiment, where intestinal epithelial cells (HCT-116) were
pretreated with chlorophyllin at 50 µM for 60 min prior to challenge with endotoxin (LPS) or TNF-alpha for 15 min. Western blot analysis for the proteins of IKK,
phosphor-IKK, I-kappa B, and phosphor-I-kappa B. (C) Cellular fractionation to measure nuclear localization for NF-kappa B/p65. The proteins in the nuclei were
marked by histone H3 and nuclear matrix, lamin A/C, while cytoplasmic proteins are indicated via GAPDH. The data pooled two repeating experiment.
been demonstrated by our recent work, showing that oral
administration of cationic resin can deplete gut endotoxin and
relieve hepatic inflammation, steatosis, and fibrosis (Zhu et al.,
2017). Bacteroidetes and Firmicutes are the two major phyla
of the gut microbiome; the former consist of Gram-negative
bacteria. Thus, it is likely that death of Bacteroidetes (showing
as reduced abundance in the gut microbiota) may contribute
to bacterial translocation, endotoxemia, systemic and hepatic
inflammation, and liver fibrogenesis. However, the integrity of
small intestine, including its innate immunity, anti-microbe
peptides, mucosa, and tight junctions and the consequent gut
eubiosis are two critical factors for host defense and metabolic
homeostasis.
Chlorophyllin is a water-soluble salt that is semi-synthesized
from chlorophyll. Its most common form is a sodium/copper
derivative that can be used as a food additive and is used in
alternative medicine. It is also widely used as a food-coloring
agent. Through its flat chlorin ring, chlorophyllin is able to
bind to environmental mutagens such as polycyclic aromatic
hydrocarbons (Breinholt et al., 1995; Blum et al., 2001). In
an animal model, dietary supplementation of chlorophyllin at
4 mg/kg body weight inhibited the development of MNNG-
induced forestomach carcinomas via down-regulation of
the expression of TGF-beta RI, TGFbeta RII, and Smad
2 and 4 and up-regulation of Smad 7, thus abrogating
canonical TGF-beta signaling (Thiyagarajan et al., 2014).
A further study showed that dietary chlorophyllin can
abrogate 7,12-dimethylbenz-anthracene (DMBA)-induced
hamster buccal pouch (HBP) carcinogenesis; furthermore,
the authors showed that Wnt/beta-catenin and VEGF
signaling are suppressed by chlorophyllin (Nagini et al.,
2012).
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FIGURE 6 | Dysbiosis occurring in the liver fibrosis can be rebalanced by oral administration of chlorophyllin for eubiosis. (A) Sketch of the experimental design.
(B–E) The fecal microbiome of mice as described in Figure 1 was measured via 16S rDNA-qPCR analysis. Relative abundance of Firmicutes and Bacteroidetes in
the three conditions was shown and related to endotoxin in plasma, consequently reduced hepatic inflammation and fibrogenesis. (F–H) Acute impact of oral
administration of chlorophyllin on the gut microbiota. Liver fibrotic mice received two doses of chlorophyllin through oral gavage, at 5 and 25 µg/g, respectively.
Feces were collected at the indicated time points for 16S rDNA-qPCR analysis. ∗P < 0.05, ∗∗P < 0.01. ∗/∗∗ Comparisons have been indicated with bars. Data show
Means ± SEM.
In this study we found that chlorophyllin is able to ameliorate
the hepatic toxin induced liver fibrosis. Mechanistically,
chlorophyllin may work on two levels. First, we found that
chlorophyllin can directly impact intestinal epithelial cells
and suppress inflammatory signals that are initiated by LPS
and TNF-alpha. The targeting action could work in the
signaling pathways, since chlorophyllin can attenuate IKK
phosphorylation and the consequent I kappa-B phosphorylation
and degradation and ultimately, the nuclear translocation
of p65. Whether chlorophyllin interacts with the receptors
of the inflammatory ligand remains unknown and should
be addressed in further studies. Another possibility is the
interaction with plasma membrane through its flat chlorin
ring. Secondly, we found that chlorophyllin can directly
impact the gut microbiota. In particular, administration of
chlorophyllin can promptly restore eubiosis, showing restoration
of Bacteroidetes and reduction of Firmicutes. Such a finding is
important because it can also explain the observed reduction
of plasma endotoxin, preassembling through the prevention
of the death of Bacteroidetes, the Gram-negative bacteria
that may contribute to the plasma endotoxin via intestinal-
hepatic circulation. Our recently published study reported
that administration of cationic resin (cholestyramine) could
sufficiently attenuate liver fibrosis induced by high-fat diet
along with vitamin D deficiency (Zhu et al., 2017). In such
a scenario, chlorophyllin may work as a prebiotic that can
modulate gut microbiota. Whether chlorophyllin can directly
suppress Firmicutes in the gut remains a subject under
investigation. LPS binding induces dimerization of the TLR4–
MD-2 complex, which is proposed to enable dimerization
of the intracellular TIR domains and recruitment of adaptor
molecules such as MyD88. We speculated the flat ring structure
of chlorophyllin might directly insert into endotoxin and
impair the binding to TLR4 on the membrane. For this regard,
using Isothermal Titration Calorimetry (ITC) we measured
the disassociation constant (Kd) between chlorophyllin
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and LPS,but the results were inconclusive and further study is
needed to address the mechanism of chlorophyllin in the cells.
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